ID   CPT1C_HUMAN             Reviewed;         803 AA.
AC   Q8TCG5; A8K0Z8; Q5K6N5; Q8N6Q9; Q8NDS6; Q8TE84;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   10-MAY-2017, entry version 127.
DE   RecName: Full=Carnitine O-palmitoyltransferase 1, brain isoform;
DE            Short=CPT1-B;
DE            EC=2.3.1.21;
DE   AltName: Full=CPT IC;
DE   AltName: Full=Carnitine O-palmitoyltransferase I, brain isoform;
DE            Short=CPTI-B;
DE   AltName: Full=Carnitine palmitoyltransferase 1C;
GN   Name=CPT1C; Synonyms=CATL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Eye;
RX   PubMed=12376098; DOI=10.1006/geno.2002.6845;
RA   Price N., van der Leij F.R., Jackson V., Corstorphine C., Thomson R.,
RA   Sorensen A., Zammit V.;
RT   "A novel brain-expressed protein related to carnitine
RT   palmitoyltransferase I.";
RL   Genomics 80:433-442(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Scorilas A., Katsaros N.;
RT   "Molecular characterization, chromosomal localization and expression
RT   analysis of a gene, CATL1, encoding for a new member of the human
RT   carnitine acyltransferase family.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Kidney epithelium, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 375-803 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   FUNCTION, INTERACTION WITH ATL1, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INVOLVEMENT IN SPG73, VARIANT SPG73 CYS-37, AND
RP   CHARACTERIZATION OF VARIANT SPG73 CYS-37.
RX   PubMed=25751282; DOI=10.1001/jamaneurol.2014.4769;
RA   Rinaldi C., Schmidt T., Situ A.J., Johnson J.O., Lee P.R., Chen K.L.,
RA   Bott L.C., Fado R., Harmison G.H., Parodi S., Grunseich C.,
RA   Renvoise B., Biesecker L.G., De Michele G., Santorelli F.M., Filla A.,
RA   Stevanin G., Duerr A., Brice A., Casals N., Traynor B.J.,
RA   Blackstone C., Ulmer T.S., Fischbeck K.H.;
RT   "Mutation in CPT1C Associated with pure autosomal dominant spastic
RT   paraplegia.";
RL   JAMA Neurol. 72:561-570(2015).
CC   -!- FUNCTION: May play a role in lipid metabolic process.
CC       {ECO:0000269|PubMed:25751282}.
CC   -!- CATALYTIC ACTIVITY: Palmitoyl-CoA + L-carnitine = CoA + L-
CC       palmitoylcarnitine.
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC   -!- SUBUNIT: Peripherally associated with AMPAR complex. AMPAR complex
CC       consists of an inner core made of 4 pore-forming GluA/GRIA
CC       proteins (GRIA1, GRIA2, GRIA3 and GRIA4) and 4 major auxiliary
CC       subunits arranged in a twofold symmetry. One of the two pairs of
CC       distinct binding sites is occupied either by CNIH2, CNIH3 or
CC       CACNG2, CACNG3. The other harbors CACNG2, CACNG3, CACNG4, CACNG8
CC       or GSG1L. This inner core of AMPAR complex is complemented by
CC       outer core constituents binding directly to the GluA/GRIA proteins
CC       at sites distinct from the interaction sites of the inner core
CC       constituents. Outer core constituents include at least PRRT1,
CC       PRRT2, CKAMP44/SHISA9, FRRS1L and NRN1. The proteins of the inner
CC       and outer core serve as a platform for other, more peripherally
CC       associated AMPAR constituents, including CPT1C. Alone or in
CC       combination, these auxiliary subunits control the gating and
CC       pharmacology of the AMPAR complex and profoundly impact their
CC       biogenesis and protein processing (By similarity). Interacts with
CC       ATL1 (PubMed:25751282). {ECO:0000250|UniProtKB:Q8BGD5,
CC       ECO:0000269|PubMed:25751282}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q8BGD5}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:25751282}. Cell projection, axon
CC       {ECO:0000269|PubMed:25751282}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:Q8BGD5}. Note=Localized in the soma and
CC       dendritic and axonal projections. {ECO:0000269|PubMed:25751282}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TCG5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TCG5-2; Sequence=VSP_010677;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8TCG5-3; Sequence=VSP_012457;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in brain and testis.
CC       Expressed in motor neurons. {ECO:0000269|PubMed:12376098,
CC       ECO:0000269|PubMed:25751282}.
CC   -!- DISEASE: Spastic paraplegia 73, autosomal dominant (SPG73)
CC       [MIM:616282]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness
CC       and spasticity of the lower limbs. Rate of progression and the
CC       severity of symptoms are quite variable. Initial symptoms may
CC       include difficulty with balance, weakness and stiffness in the
CC       legs, muscle spasms, and dragging the toes when walking. In some
CC       forms of the disorder, bladder symptoms (such as incontinence) may
CC       appear, or the weakness and stiffness may spread to other parts of
CC       the body. {ECO:0000269|PubMed:25751282}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the carnitine/choline acetyltransferase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB85068.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAD38561.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF357970; AAL99615.1; -; mRNA.
DR   EMBL; AF331918; AAQ14875.1; -; Genomic_DNA.
DR   EMBL; AK074389; BAB85068.1; ALT_INIT; mRNA.
DR   EMBL; AK289713; BAF82402.1; -; mRNA.
DR   EMBL; AK290092; BAF82781.1; -; mRNA.
DR   EMBL; CH471177; EAW52524.1; -; Genomic_DNA.
DR   EMBL; BC029104; AAH29104.1; -; mRNA.
DR   EMBL; AL831876; CAD38561.2; ALT_INIT; mRNA.
DR   CCDS; CCDS12779.1; -. [Q8TCG5-1]
DR   CCDS; CCDS46147.1; -. [Q8TCG5-2]
DR   RefSeq; NP_001129524.1; NM_001136052.2. [Q8TCG5-2]
DR   RefSeq; NP_001186681.1; NM_001199752.2. [Q8TCG5-1]
DR   RefSeq; NP_001186682.1; NM_001199753.1. [Q8TCG5-1]
DR   RefSeq; NP_689572.1; NM_152359.2. [Q8TCG5-1]
DR   RefSeq; XP_005258562.1; XM_005258505.2. [Q8TCG5-1]
DR   RefSeq; XP_005258563.1; XM_005258506.4. [Q8TCG5-1]
DR   RefSeq; XP_011524740.1; XM_011526438.2. [Q8TCG5-1]
DR   RefSeq; XP_011524741.1; XM_011526439.2. [Q8TCG5-1]
DR   UniGene; Hs.112195; -.
DR   PDB; 2M76; NMR; -; A=1-50.
DR   PDBsum; 2M76; -.
DR   ProteinModelPortal; Q8TCG5; -.
DR   SMR; Q8TCG5; -.
DR   MINT; MINT-6631074; -.
DR   STRING; 9606.ENSP00000319343; -.
DR   iPTMnet; Q8TCG5; -.
DR   PhosphoSitePlus; Q8TCG5; -.
DR   BioMuta; CPT1C; -.
DR   DMDM; 57013809; -.
DR   PaxDb; Q8TCG5; -.
DR   PeptideAtlas; Q8TCG5; -.
DR   PRIDE; Q8TCG5; -.
DR   DNASU; 126129; -.
DR   Ensembl; ENST00000323446; ENSP00000319343; ENSG00000169169. [Q8TCG5-1]
DR   Ensembl; ENST00000392518; ENSP00000376303; ENSG00000169169. [Q8TCG5-1]
DR   Ensembl; ENST00000405931; ENSP00000384465; ENSG00000169169. [Q8TCG5-2]
DR   Ensembl; ENST00000598293; ENSP00000473028; ENSG00000169169. [Q8TCG5-1]
DR   GeneID; 126129; -.
DR   KEGG; hsa:126129; -.
DR   UCSC; uc002ppj.4; human. [Q8TCG5-1]
DR   CTD; 126129; -.
DR   DisGeNET; 126129; -.
DR   GeneCards; CPT1C; -.
DR   HGNC; HGNC:18540; CPT1C.
DR   HPA; HPA014529; -.
DR   MalaCards; CPT1C; -.
DR   MIM; 608846; gene.
DR   MIM; 616282; phenotype.
DR   neXtProt; NX_Q8TCG5; -.
DR   OpenTargets; ENSG00000169169; -.
DR   PharmGKB; PA134922321; -.
DR   eggNOG; KOG3717; Eukaryota.
DR   eggNOG; ENOG410XNZ9; LUCA.
DR   GeneTree; ENSGT00760000119220; -.
DR   HOGENOM; HOG000233542; -.
DR   HOVERGEN; HBG003458; -.
DR   InParanoid; Q8TCG5; -.
DR   KO; K19524; -.
DR   OMA; IDCHVFP; -.
DR   OrthoDB; EOG091G026C; -.
DR   PhylomeDB; Q8TCG5; -.
DR   TreeFam; TF313836; -.
DR   BioCyc; MetaCyc:HS09892-MONOMER; -.
DR   BRENDA; 2.3.1.21; 2681.
DR   SIGNOR; Q8TCG5; -.
DR   UniPathway; UPA00659; -.
DR   GenomeRNAi; 126129; -.
DR   PRO; PR:Q8TCG5; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000169169; -.
DR   CleanEx; HS_CPT1C; -.
DR   ExpressionAtlas; Q8TCG5; baseline and differential.
DR   Genevisible; Q8TCG5; HS.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IEA:Ensembl.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0004095; F:carnitine O-palmitoyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009437; P:carnitine metabolic process; IEA:Ensembl.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR000542; Carn_acyl_trans.
DR   InterPro; IPR032476; CPT_N.
DR   PANTHER; PTHR22589; PTHR22589; 1.
DR   Pfam; PF00755; Carn_acyltransf; 1.
DR   Pfam; PF16484; CPT_N; 1.
DR   PROSITE; PS00439; ACYLTRANSF_C_1; 1.
DR   PROSITE; PS00440; ACYLTRANSF_C_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Alternative splicing; Cell junction;
KW   Cell projection; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Fatty acid metabolism;
KW   Hereditary spastic paraplegia; Lipid metabolism; Membrane;
KW   Mitochondrion; Mitochondrion outer membrane; Neurodegeneration;
KW   Reference proteome; Synapse; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    803       Carnitine O-palmitoyltransferase 1, brain
FT                                isoform.
FT                                /FTId=PRO_0000210166.
FT   TOPO_DOM      1     52       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     53     75       Helical. {ECO:0000255}.
FT   TOPO_DOM     76    103       Mitochondrial intermembrane.
FT                                {ECO:0000255}.
FT   TRANSMEM    104    126       Helical. {ECO:0000255}.
FT   TOPO_DOM    127    803       Cytoplasmic. {ECO:0000255}.
FT   REGION      552    564       Coenzyme A binding. {ECO:0000250}.
FT   ACT_SITE    470    470       Proton acceptor. {ECO:0000250}.
FT   BINDING     586    586       Carnitine. {ECO:0000250}.
FT   BINDING     588    588       Carnitine. {ECO:0000250}.
FT   BINDING     589    589       Coenzyme A. {ECO:0000250}.
FT   BINDING     599    599       Carnitine. {ECO:0000250}.
FT   VAR_SEQ     258    268       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010677.
FT   VAR_SEQ     623    711       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_012457.
FT   VARIANT      37     37       R -> C (in SPG73; alters protein
FT                                conformation; dominant negative mutation;
FT                                dbSNP:rs786204767).
FT                                {ECO:0000269|PubMed:25751282}.
FT                                /FTId=VAR_073433.
FT   CONFLICT     58     58       S -> G (in Ref. 3; BAF82402).
FT                                {ECO:0000305}.
FT   CONFLICT    375    378       HEEH -> RTRG (in Ref. 6; CAD38561).
FT                                {ECO:0000305}.
FT   CONFLICT    542    542       D -> G (in Ref. 3; BAB85068).
FT                                {ECO:0000305}.
FT   TURN         13     15       {ECO:0000244|PDB:2M76}.
FT   HELIX        25     48       {ECO:0000244|PDB:2M76}.
SQ   SEQUENCE   803 AA;  90989 MW;  96C2AE6ED0DEC705 CRC64;
     MAEAHQAVGF RPSLTSDGAE VELSAPVLQE IYLSGLRSWK RHLSRFWNDF LTGVFPASPL
     SWLFLFSAIQ LAWFLQLDPS LGLMEKIKEL LPDWGGQHHG LRGVLAAALF ASCLWGALIF
     TLHVALRLLL SYHGWLLEPH GAMSSPTKTW LALVRIFSGR HPMLFSYQRS LPRQPVPSVQ
     DTVRKYLESV RPILSDEDFD WTAVLAQEFL RLQASLLQWY LRLKSWWASN YVSDWWEEFV
     YLRSRNPLMV NSNYYMMDFL YVTPTPLQAA RAGNAVHALL LYRHRLNRQE IPPTLLMGMR
     PLCSAQYEKI FNTTRIPGVQ KDYIRHLHDS QHVAVFHRGR FFRMGTHSRN SLLSPRALEQ
     QFQRILDDPS PACPHEEHLA ALTAAPRGTW AQVRTSLKTQ AAEALEAVEG AAFFVSLDAE
     PAGLTREDPA ASLDAYAHAL LAGRGHDRWF DKSFTLIVFS NGKLGLSVEH SWADCPISGH
     MWEFTLATEC FQLGYSTDGH CKGHPDPTLP QPQRLQWDLP DQIHSSISLA LRGAKILSEN
     VDCHVVPFSL FGKSFIRRCH LSSDSFIQIA LQLAHFRDRG QFCLTYESAM TRLFLEGRTE
     TVRSCTREAC NFVRAMEDKE KTDPQCLALF RVAVDKHQAL LKAAMSGQGV DRHLFALYIV
     SRFLHLQSPF LTQVHSEQWQ LSTSQIPVQQ MHLFDVHNYP DYVSSGGGFG PADDHGYGVS
     YIFMGDGMIT FHISSKKSST KTDSHRLGQH IEDALLDVAS LFQAGQHFKR RFRGSGKENS
     RHRCGFLSRQ TGASKASMTS TDF
//
